Current treatment practices in the management of cutaneous haemangioma

Expert Opinion on Pharmacotherapy
Yuin-Chew Chan

Abstract

Haemangiomas are common, benign tumours of the vascular endothelium which present within the first few weeks of life. Clinically, they are very heterogeneous, with size, location and rate of proliferation having a significant effect on the risk of complications. Most haemangiomas are uncomplicated, and can be observed for spontaneous involution. However, some may be life- or function-threatening and require treatment. Corticosteroids, which may be used topically, intralesionally or systematically, are the mainstay of therapy. IFN-alpha, vincristine and cyclophosphamide are therapeutic options for complicated haemangiomas which do not respond to corticosteroids. Vascular-specific laser therapy may be considered for superficial haemangiomas, ulcerated haemangiomas or postinvolution sequelae, such as telangiectasia. A periorbital haemangioma that obstructs the visual axis or exerts pressure on the globe is an ocular emergency; systemic corticosteroids and patching of the unaffected eye should be instituted as soon as possible.

References

May 28, 1992·The New England Journal of Medicine·R A EzekowitzJ Folkman
Feb 1, 1991·Archives of Dermatology·R Ashinoff, R G Geronemus
Aug 1, 1989·The Journal of Dermatologic Surgery and Oncology·B A ReyesH Capo
Mar 1, 1989·Plastic and Reconstructive Surgery·G M SloanD T Morwood
Oct 1, 1985·Plastic and Reconstructive Surgery·B J Kushner
Mar 1, 1968·The Journal of Pediatrics·N C Fost, N B Esterly
Jan 1, 1967·Plastic and Reconstructive Surgery·H A Zarem, M T Edgerton
Jul 6, 1995·The New England Journal of Medicine·J Perez PayarolsC Gomez Bellvert
Oct 1, 1994·Archives of Pediatrics & Adolescent Medicine·J G MorelliW L Weston
Jul 1, 1993·The Annals of Pharmacotherapy·D K Boehm, N L Kobrinsky
Mar 1, 1993·Pediatric Dermatology·R Ashinoff, R G Geronemus
Jul 1, 1995·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·E J Battegay
Jan 1, 1996·The Journal of Pediatrics·N Sadan, B Wolach
Mar 1, 1996·The Journal of Pediatrics·L M BoonJ B Mulliken
Jun 1, 1996·Annals of Plastic Surgery·I PitanguyN F Amorim
Apr 1, 1997·The Journal of Pediatrics·O EnjolrasJ P Escande
May 1, 1997·Journal of Pediatric Hematology/oncology·E ChangV P Castle
Jul 1, 1997·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·N M BaumanR J Smith
Apr 17, 1998·The Journal of Pediatrics·C F BarlowR A Ezekowitz
Feb 5, 1999·Archives of Otolaryngology--head & Neck Surgery·J H GreinwaldR J Smith
Jul 15, 1999·The New England Journal of Medicine·B A DroletI J Frieden
Dec 29, 2000·Journal of Pediatric Hematology/oncology·S A HurvitzM C Sanford
Jun 8, 2001·Plastic and Reconstructive Surgery·O EnjolrasP E Burrows
Aug 2, 2001·Journal of Pediatric Surgery·J MooreJ Kandel
Jul 1, 1955·Acta Paediatrica·K HOLMDAHL
Feb 6, 2004·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·O EnjolrasG Leverger
Mar 24, 2004·British Journal of Plastic Surgery·S L FawcettJ C Nicholson

❮ Previous
Next ❯

Citations

Mar 4, 2009·Clinical Rheumatology·S HabibiG Narsimulu
Dec 22, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·R López AlmarazG Ramírez Villar
Sep 3, 2014·European Journal of Pediatrics·Sherief R JanmohamedArnold P Oranje
Apr 10, 2008·International Journal of STD & AIDS·Medhat S T BastaMayur Chauhan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.